Dimethylformamide

Dimethylformamide

SCHEMBL7200371

Br.CN(C)C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Dimethylformamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109851549-B 5-hydrogen-benzo [ b ] carbazole and related derivatives and synthetic method thereof 西安欧得光电材料有限公司 2022-03-29 CN claimed
WO-2023221234-A1 IN VITRO SCREENING METHOD FOR COVALENT INHIBITOR AND USE THEREOF 清华大学 2023-11-23 WO disclosed
CN-109851549-B 5-hydrogen-benzo [ b ] carbazole and related derivatives and synthetic method thereof 西安欧得光电材料有限公司 2022-03-29 CN disclosed
CN-110183491-A A method of recycling by-product p-methyl benzenesulfonic acid magnesium synthesis tenofovir 黄石福尔泰医药科技有限公司 2019-08-30 CN disclosed
CN-109476641-A Heterocyclic inhibitors of CBP/EP300 and their use in the treatment of cancer 基因泰克公司 2019-03-15 CN disclosed
CN-101381379-A Kinase inhibitor phosphonate conjugates GILEAD SCIENCES INC (US) 2009-03-11 CN disclosed
CN-1819832-A Kinase inhibitory phosphonate analogs GILEAD SCIENCES INC (US) 2006-08-16 CN disclosed
CN-1780631-A anticancer phosphonate analogs GILEAD SCIENCES INC (US) 2006-05-31 CN disclosed
US-6593319-B1 Novel 17,20-dihydrofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections. LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) 2003-07-15 US disclosed
EP-1232173-B1 FUSIDIC ACID DERIVATIVES LEO PHARM PROD LTD (DK) 2003-05-28 EP disclosed
EP-1232173-A1 FUSIDIC ACID DERIVATIVES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-08-21 EP disclosed
WO-2001029061-A1 NOVEL FUSIDIC ACID DERIVATIVES Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-04-26 WO disclosed
CN-87102944-A Ergolene derivatives, pharmaceutical compositions and process for preparing them 1987-11-25 CN disclosed
US-4150047-A AMIDE SOLVENT, LEWIS ACID AIR PRODUCTS AND CHEMICALS, INC. (US) 1979-04-17 US disclosed